The insider sales are too small in dollar terms to signal bearish conviction. Monitor for any material news (pipeline data, regulatory updates) that could explain the timing, but the cluster alone does not warrant a trading action.
Price Chart
Executive Summary
Two C-suite insiders at Candel Therapeutics sold $306K in open-market sales on June 29, 2026, while a third insider received a non-cash grant. The sales represent ~0.04% of the $724M market cap, well below the 0.1% materiality threshold. The cluster is small in dollar terms and likely driven by routine portfolio diversification rather than negative conviction.
Key Financial Metrics
Key Facts
- Chief Scientific Officer Francesca Barone sold 23,400 shares at $10.06 for $236K on 2026-06-29
- Chief Technology Officer Seshu Tyagarajan sold 7,000 shares at $10.02 for $70K on 2026-06-29
- Chief Commercial Officer Mark E. Sims received a non-cash grant of 285,000 shares at $0 on 2026-07-06
- Total open-market sales of $306K represent ~0.04% of the $724M market cap
- Both sales occurred on the same day, suggesting a shared blackout-window opening or 10b5-1 plan
Financial Impact
Open-market sales of $306K, representing 0.04% of market cap — trivial relative to company size
Risk Factors
- Insider sales could accelerate if the stock continues to rise, but current activity is routine
- No evidence of informed selling — the cluster is likely liquidity-driven
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CADL-1783577357273 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | Press Release | $10.16 | awaiting T+60 | — | $7.79 (−23.33%) |
Sep 30, 2026 26d ago | Press Release | $10.44 | awaiting T+60 | — | $7.79 (−25.38%) |
Sep 10, 2026 6w ago | 8-K | $11.33 | awaiting T+60 | — | $7.79 (−31.24%) |
Sep 9, 2026 6w ago | 8-K | $11.33 | awaiting T+60 | — | $7.79 (−31.24%) |
Aug 15, 2026 10w ago | Institutional Cluster | $12.16 | awaiting T+60 | — | $7.79 (−35.94%) |
Aug 13, 2026 10w ago | 8-K | $11.80 | awaiting T+60 | — | $7.79 (−33.98%) |
Aug 13, 2026 10w ago | Press Release | $11.80 | awaiting T+60 | — | $7.79 (−33.98%) |
Aug 3, 2026 12w ago | Press Release | $10.07 | awaiting T+60 | — | $7.79 (−22.64%) |
Jul 1, 2026 16w ago | Insider Cluster | $9.83 $11.19 | ▲ +13.84% | ▲ +11.04% | $7.79 (−20.75%) |
Jul 1, 2026 16w ago | Insider Cluster | $9.83 $11.19 | ▲ +13.84% | ▲ +11.04% | $7.79 (−20.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers